Results for tag: "Splenomegaly Drug"

Splenomegaly is a condition in which the spleen enlarges beyond its normal size. It is a common symptom of various gastrointestinal diseases, such as cirrhosis, hepatitis, and portal hypertension. As such, splenomegaly is often treated with drugs that target the underlying cause of the condition. These drugs are typically classified as gastrointestinal drugs, and include antibiotics, antivirals, antifungals, and immunosuppressants. Gastrointestinal drugs are used to treat a wide range of conditions, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. The splenomegaly drug market is a subset of the larger gastrointestinal drug market, and includes drugs specifically designed to treat the enlargement of the spleen. Some companies in the splenomegaly drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more